This is a Validated Antibody Database (VAD) review about human EPCAM, based on 139 published articles (read how Labome selects the articles), using EPCAM antibody in all methods. It is aimed to help Labome visitors find the most suited EPCAM antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
EPCAM synonym: DIAR5; EGP-2; EGP314; EGP40; ESA; HNPCC8; KS1/4; KSA; M4S1; MIC18; MK-1; TACSTD1; TROP1

Knockout validation
Abcam
domestic rabbit polyclonal
  • immunohistochemistry knockout validation; mouse; loading ...; fig 2b
Abcam EPCAM antibody (Abcam, ab71916) was used in immunohistochemistry knockout validation on mouse samples (fig 2b). Int J Mol Med (2019) ncbi
Abcam
domestic rabbit monoclonal (E144)
  • western blot knockout validation; mouse; fig 5e
Abcam EPCAM antibody (Abcam, ab32392) was used in western blot knockout validation on mouse samples (fig 5e). Am J Physiol Gastrointest Liver Physiol (2014) ncbi
BioLegend
mouse monoclonal (9C4)
  • flow cytometry; human; loading ...; fig 2a
BioLegend EPCAM antibody (BioLegend, 324207) was used in flow cytometry on human samples (fig 2a). Nat Commun (2021) ncbi
mouse monoclonal (9C4)
  • immunohistochemistry; human; loading ...
BioLegend EPCAM antibody (Biolegend, 324203) was used in immunohistochemistry on human samples . elife (2021) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; 1:20; fig s3c
BioLegend EPCAM antibody (BioLegend, 324210) was used in flow cytometry on human samples at 1:20 (fig s3c). Nat Commun (2020) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; loading ...; fig 1d, s1i
BioLegend EPCAM antibody (Biolegend, 324205) was used in flow cytometry on human samples (fig 1d, s1i). Cell Rep (2019) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; 1:100; loading ...; fig e4f
BioLegend EPCAM antibody (Biolegend, 324215) was used in flow cytometry on human samples at 1:100 (fig e4f). Nature (2019) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; loading ...; fig ex2a
BioLegend EPCAM antibody (BioLegend, 9C4) was used in flow cytometry on human samples (fig ex2a). Nature (2019) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; 1:200; loading ...; fig s7
BioLegend EPCAM antibody (Biolegend, 324204) was used in flow cytometry on human samples at 1:200 (fig s7). Nat Methods (2019) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; loading ...; fig 2e
BioLegend EPCAM antibody (Biolegend, 324222) was used in flow cytometry on human samples (fig 2e). Cancer Cell (2019) ncbi
mouse monoclonal (9C4)
  • mass cytometry; human; loading ...; fig 1b
BioLegend EPCAM antibody (Biolegend, 324202) was used in mass cytometry on human samples (fig 1b). Cell (2019) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; 1:100; loading ...; fig 11a
BioLegend EPCAM antibody (BioLegend, 324205) was used in flow cytometry on human samples at 1:100 (fig 11a). Nat Commun (2019) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; loading ...
BioLegend EPCAM antibody (BioLegend, 324208) was used in flow cytometry on human samples . Cell (2019) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; fig 3c
BioLegend EPCAM antibody (BioLegend, 324208) was used in flow cytometry on human samples (fig 3c). J Exp Med (2019) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; loading ...; fig 1b
BioLegend EPCAM antibody (Biolegend, 9C4) was used in flow cytometry on human samples (fig 1b). Cell Stem Cell (2019) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; loading ...; fig 1a
BioLegend EPCAM antibody (BioLegend, 324205) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; loading ...; fig 9b
BioLegend EPCAM antibody (BioLegend, 9C4) was used in flow cytometry on human samples (fig 9b). J Cell Biol (2018) ncbi
mouse monoclonal (9C4)
  • immunohistochemistry; human; loading ...; fig 2c
BioLegend EPCAM antibody (BioLegend, 9C4) was used in immunohistochemistry on human samples (fig 2c). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; 1:100; loading ...; fig 1f
BioLegend EPCAM antibody (BioLegend, 324222) was used in flow cytometry on human samples at 1:100 (fig 1f). Stem Cell Res (2018) ncbi
mouse monoclonal (9C4)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1
In order to investigate the efficacy of codelivering engineered T cells and STING agonists in cancer therapy, BioLegend EPCAM antibody (BioLegend, 324228) was used in immunohistochemistry - paraffin section on human samples (fig 1). J Clin Invest (2017) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; 1:100; fig 3a
In order to investigate how LACTB suppresses breast cancer cell growth, BioLegend EPCAM antibody (BioLegend, 324218) was used in flow cytometry on human samples at 1:100 (fig 3a). Nature (2017) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; 1:25; loading ...; fig 3a
In order to define the interaction between LATS1/2 and the estrogen receptor signaling in breast cancer initiation., BioLegend EPCAM antibody (BioLegend, 9C4) was used in flow cytometry on human samples at 1:25 (fig 3a). Nature (2017) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; fig 7c
In order to determine the rotavirus NSP1-host protein interaction network, BioLegend EPCAM antibody (Biolegend, 324206) was used in flow cytometry on human samples (fig 7c). PLoS Pathog (2016) ncbi
mouse monoclonal (9C4)
BioLegend EPCAM antibody (BioLegend, 324216) was used . Nat Commun (2016) ncbi
mouse monoclonal (9C4)
BioLegend EPCAM antibody (BioLegend, 324208) was used . Sci Rep (2016) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; 1:20; fig 2a
In order to analyze propagation of oestrogen-responsive and oestrogen receptor-positive normal human breast cells in culture, BioLegend EPCAM antibody (BioLegend, 324214) was used in flow cytometry on human samples at 1:20 (fig 2a). Nat Commun (2015) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; fig 10c
In order to study functional receptors for cholera toxin by fucosylation and protein glycosylation, BioLegend EPCAM antibody (BioLegend, 9C4) was used in flow cytometry on human samples (fig 10c). elife (2015) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; fig 2
BioLegend EPCAM antibody (BioLegend , #324203) was used in flow cytometry on human samples (fig 2). Int J Cancer (2016) ncbi
mouse monoclonal (9C4)
  • immunocytochemistry; human; tbl 2
BioLegend EPCAM antibody (Biolegend, 324212) was used in immunocytochemistry on human samples (tbl 2). Exp Cell Res (2015) ncbi
mouse monoclonal (9C4)
  • immunohistochemistry - frozen section; human; fig 1
  • flow cytometry; human; fig 1
In order to examine the contribution of stromal cells to non-small cell lung cancer, BioLegend EPCAM antibody (BioLegend, 9C4) was used in immunohistochemistry - frozen section on human samples (fig 1) and in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (9C4)
  • immunocytochemistry; human
BioLegend EPCAM antibody (Biolegend, 324212) was used in immunocytochemistry on human samples . Nanomedicine (2015) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; fig 6
BioLegend EPCAM antibody (BioLegend, G9C4) was used in flow cytometry on human samples (fig 6). Stem Cells Dev (2015) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human
BioLegend EPCAM antibody (Biolegend, 324219) was used in flow cytometry on human samples . Oncotarget (2015) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; fig 4
In order to analyze cancer cell plasticity autonomous stimulation by human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells, BioLegend EPCAM antibody (Biolegend, 9C4) was used in flow cytometry on human samples (fig 4). PLoS ONE (2014) ncbi
mouse monoclonal (9C4)
  • western blot; human; 1:1000
BioLegend EPCAM antibody (Biolegend, 324202) was used in western blot on human samples at 1:1000. Cell (2014) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; loading ...; fig 2b
In order to study the role of TH9 cells in ulcerative colitis, BioLegend EPCAM antibody (BioLegend, 9C4) was used in flow cytometry on human samples (fig 2b). Nat Immunol (2014) ncbi
mouse monoclonal (9C4)
BioLegend EPCAM antibody (Biolegend, 9c4) was used . PLoS ONE (2014) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; 1:25
BioLegend EPCAM antibody (Biolegend, 9C4) was used in flow cytometry on human samples at 1:25. Gut (2015) ncbi
mouse monoclonal (9C4)
  • flow cytometry; human; fig 1c
In order to study granulocyte colony-stimulating factor signaling in gastrointestinal tumors, BioLegend EPCAM antibody (Biolegend, 9c4) was used in flow cytometry on human samples (fig 1c). Br J Cancer (2014) ncbi
Abcam
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; loading ...; fig s1
Abcam EPCAM antibody (ABCAM, ab71916) was used in immunohistochemistry - paraffin section on human samples (fig s1). Adv Sci (Weinh) (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; mouse; 1:1500; loading ...; fig 3a
Abcam EPCAM antibody (Abcam, ab71916) was used in immunohistochemistry - paraffin section on mouse samples at 1:1500 (fig 3a). Sci Adv (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:20,000; loading ...; fig 2f, 2g
Abcam EPCAM antibody (abcam, ab71916) was used in immunohistochemistry - paraffin section on human samples at 1:20,000 (fig 2f, 2g). Cancers (Basel) (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; human; 1:100; loading ...; fig 2s1d
Abcam EPCAM antibody (Abcam, ab71916) was used in immunohistochemistry - frozen section on human samples at 1:100 (fig 2s1d). elife (2020) ncbi
domestic rabbit monoclonal (E144)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig ev1e
Abcam EPCAM antibody (Abcam, ab32392) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig ev1e). EMBO Rep (2020) ncbi
mouse monoclonal (HEA125)
  • immunocytochemistry; human; 1:200; loading ...; fig 5b
Abcam EPCAM antibody (Abcam, ab46714) was used in immunocytochemistry on human samples at 1:200 (fig 5b). Biores Open Access (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry; mouse; 1:1200; loading ...; fig 2a
Abcam EPCAM antibody (Abcam, ab71916) was used in immunohistochemistry on mouse samples at 1:1200 (fig 2a). Dis Model Mech (2020) ncbi
domestic rabbit polyclonal
  • immunohistochemistry knockout validation; mouse; loading ...; fig 2b
Abcam EPCAM antibody (Abcam, ab71916) was used in immunohistochemistry knockout validation on mouse samples (fig 2b). Int J Mol Med (2019) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig s7c
Abcam EPCAM antibody (Abcam, Ab-71916) was used in western blot on mouse samples at 1:1000 (fig s7c). EMBO J (2019) ncbi
mouse monoclonal (Ber-EP4)
  • immunohistochemistry; human; 1:100; loading ...; fig 4c
Abcam EPCAM antibody (abcam, ab7504) was used in immunohistochemistry on human samples at 1:100 (fig 4c). Nat Commun (2019) ncbi
domestic rabbit monoclonal
  • immunohistochemistry - frozen section; human; fig 3d
Abcam EPCAM antibody (Abcam, ab213500) was used in immunohistochemistry - frozen section on human samples (fig 3d). J Exp Med (2019) ncbi
domestic rabbit monoclonal (E144)
  • western blot; human; 1:3000; fig 1d
Abcam EPCAM antibody (Abcam, ab32392) was used in western blot on human samples at 1:3000 (fig 1d). Mol Med Rep (2019) ncbi
domestic rabbit monoclonal (EPR677(2))
  • western blot; human; loading ...; fig 3a
Abcam EPCAM antibody (Abcam, ab124825) was used in western blot on human samples (fig 3a). J Mol Med (Berl) (2019) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:250; loading ...; fig 4g
Abcam EPCAM antibody (Abcam, ab71916) was used in immunohistochemistry - frozen section on mouse samples at 1:250 (fig 4g). Development (2017) ncbi
domestic rabbit monoclonal (E144)
  • western blot; human; loading ...; fig 3d
Abcam EPCAM antibody (Thermo Fisher, ab32392) was used in western blot on human samples (fig 3d). Carcinogenesis (2017) ncbi
mouse monoclonal (AUA1)
  • immunocytochemistry; human; fig 3c
In order to study the contribution of Wnt signaling to the development of functional proximal airway organoids, Abcam EPCAM antibody (Abcam, ab20160) was used in immunocytochemistry on human samples (fig 3c). Cell Stem Cell (2017) ncbi
domestic rabbit monoclonal (E144)
  • western blot; mouse; loading ...; fig s2a
In order to establish that epithelial cell adhesion molecule and extracellular domain of EpCAM enhance the efficiency of OSKM reprogramming, Abcam EPCAM antibody (Abcam, E144) was used in western blot on mouse samples (fig s2a). Sci Rep (2017) ncbi
mouse monoclonal (Ber-EP4)
  • immunohistochemistry - paraffin section; human; 1:250; loading ...; fig 4
Abcam EPCAM antibody (Abcam, ab7504) was used in immunohistochemistry - paraffin section on human samples at 1:250 (fig 4). Oncol Lett (2016) ncbi
mouse monoclonal (B29.1 (VU-1D9))
  • flow cytometry; human; 1:100; fig 6a
In order to evaluate the methodology of microsphere cytometry for studying cellular microenvironment, Abcam EPCAM antibody (Abcam, ab8666) was used in flow cytometry on human samples at 1:100 (fig 6a). Integr Biol (Camb) (2017) ncbi
mouse monoclonal (AUA1)
  • immunocytochemistry; human; 1:50; loading ...
Abcam EPCAM antibody (Biocare Medical, ab20160) was used in immunocytochemistry on human samples at 1:50. Int J Oncol (2017) ncbi
domestic rabbit monoclonal (E144)
  • western blot; human; fig 5
In order to characterize androgen receptor-targeted and vitamin D therapy for triple-negative breast cancer, Abcam EPCAM antibody (Abcam, ab32392) was used in western blot on human samples (fig 5). Breast Cancer Res Treat (2016) ncbi
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:200; fig s7
Abcam EPCAM antibody (Abcam, ab71916) was used in immunocytochemistry on human samples at 1:200 (fig s7). Nat Commun (2016) ncbi
domestic rabbit monoclonal (E144)
  • immunohistochemistry - paraffin section; mouse; fig 2
In order to study liver repopulation capacity of biliary origin hepatic progenitor cells, Abcam EPCAM antibody (Abcam, ab32392) was used in immunohistochemistry - paraffin section on mouse samples (fig 2). Nat Cell Biol (2015) ncbi
domestic rabbit polyclonal
  • western blot; human
In order to study how EpCAM is upregulated in HBV-mediated hepatocellular carcinoma and hepatic cancer stem cells, Abcam EPCAM antibody (Abcam, ab71916) was used in western blot on human samples . Oncogene (2016) ncbi
mouse monoclonal (AUA1)
  • western blot; human; 1:100
In order to describe a method to generate cystic fibrosis transmembrane conductance regulator protein-expressing airway epithelial cells from human pluripotent stem cells, Abcam EPCAM antibody (Abcam, ab20160) was used in western blot on human samples at 1:100. Nat Protoc (2015) ncbi
domestic rabbit monoclonal (E144)
  • immunohistochemistry - frozen section; mouse; fig 2
Abcam EPCAM antibody (abcam, E144) was used in immunohistochemistry - frozen section on mouse samples (fig 2). PLoS Pathog (2015) ncbi
domestic rabbit monoclonal (E144)
  • immunoprecipitation; human
In order to study the role of CUB domain-containing protein-1 in relation to cancer cells, Abcam EPCAM antibody (Abcam, ab32392) was used in immunoprecipitation on human samples . BMC Cancer (2014) ncbi
domestic rabbit monoclonal (E144)
  • western blot; human; 1:1000; loading ...; fig 6
Abcam EPCAM antibody (Abcam, ab32392) was used in western blot on human samples at 1:1000 (fig 6). Cell Biol Int (2015) ncbi
domestic rabbit monoclonal (E144)
  • flow cytometry; mouse; 1:500
Abcam EPCAM antibody (Abcam, ab32392) was used in flow cytometry on mouse samples at 1:500. Springerplus (2014) ncbi
domestic rabbit monoclonal (E144)
  • western blot knockout validation; mouse; fig 5e
Abcam EPCAM antibody (Abcam, ab32392) was used in western blot knockout validation on mouse samples (fig 5e). Am J Physiol Gastrointest Liver Physiol (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (0.N.276)
  • western blot; human; 1:1000; loading ...; fig 3a
Santa Cruz Biotechnology EPCAM antibody (Santa Cruz, sc-71059) was used in western blot on human samples at 1:1000 (fig 3a). Sci Rep (2021) ncbi
mouse monoclonal (EBA-1)
  • immunocytochemistry; human; 1:250; loading ...; fig 3e
Santa Cruz Biotechnology EPCAM antibody (Santa, sc-66020) was used in immunocytochemistry on human samples at 1:250 (fig 3e). elife (2021) ncbi
mouse monoclonal (323/A3)
  • immunoprecipitation; human; loading ...; fig 2d
  • immunohistochemistry; human; loading ...; fig 2b
  • western blot; human; loading ...; fig 1b
In order to test if HAI-2, matriptase, EpCAM, and claudin-7 are functionally linked in the intestine, Santa Cruz Biotechnology EPCAM antibody (Santa Cruz, 323/A30) was used in immunoprecipitation on human samples (fig 2d), in immunohistochemistry on human samples (fig 2b) and in western blot on human samples (fig 1b). J Clin Invest (2017) ncbi
mouse monoclonal (EBA-1)
  • immunoprecipitation; human; loading ...; fig 2d
  • immunohistochemistry; human; loading ...; fig 2b
  • western blot; human; loading ...; fig 1b
In order to test if HAI-2, matriptase, EpCAM, and claudin-7 are functionally linked in the intestine, Santa Cruz Biotechnology EPCAM antibody (Santa Cruz, EBA-1) was used in immunoprecipitation on human samples (fig 2d), in immunohistochemistry on human samples (fig 2b) and in western blot on human samples (fig 1b). J Clin Invest (2017) ncbi
mouse monoclonal (C-10)
  • western blot; human; fig 3a
Santa Cruz Biotechnology EPCAM antibody (Santa Cruz Biotechnology, C-10) was used in western blot on human samples (fig 3a). Sci Rep (2016) ncbi
mouse monoclonal
  • western blot; human; fig 3a
Santa Cruz Biotechnology EPCAM antibody (Santa Cruz Biotechnology, C-10) was used in western blot on human samples (fig 3a). Sci Rep (2016) ncbi
mouse monoclonal (0.N.277)
  • immunohistochemistry; human; fig 1
Santa Cruz Biotechnology EPCAM antibody (Santa Cruz, sc-59782) was used in immunohistochemistry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (HEA125)
  • immunohistochemistry - frozen section; mouse; 1:50; fig s5
In order to analyze organotropic metasistasis and tumour exosome integrins, Santa Cruz Biotechnology EPCAM antibody (Santa Cruz, HEA125) was used in immunohistochemistry - frozen section on mouse samples at 1:50 (fig s5). Nature (2015) ncbi
mouse monoclonal (C-10)
  • western blot; human; fig 1
Santa Cruz Biotechnology EPCAM antibody (Santa Cruz, C-10) was used in western blot on human samples (fig 1). J Biol Chem (2015) ncbi
mouse monoclonal (C-10)
  • western blot; human
In order to study the role of ADAM17 in cellular senescence and senescence secretome, Santa Cruz Biotechnology EPCAM antibody (Santa Cruz Biotechnologies, sc-25308) was used in western blot on human samples . Breast Cancer Res (2015) ncbi
mouse monoclonal (C-10)
  • western blot; human; fig 6
Santa Cruz Biotechnology EPCAM antibody (Santa Cruz Biotechnology, sc-25308) was used in western blot on human samples (fig 6). PLoS ONE (2015) ncbi
mouse monoclonal (0.N.277)
  • other; human; fig 2
In order to characterize capabilities and potentials of extracellular vesicle (EV) array, Santa Cruz Biotechnology EPCAM antibody (Santa Cruz Biotechnology, sc-59782) was used in other on human samples (fig 2). J Extracell Vesicles (2015) ncbi
mouse monoclonal (C-10)
  • western blot; human; fig 7
Santa Cruz Biotechnology EPCAM antibody (Santa Cruz, sc-25308) was used in western blot on human samples (fig 7). Oncotarget (2015) ncbi
mouse monoclonal (EBA-1)
  • flow cytometry; human; 1:25
In order to characterize human tracheal basal cells, Santa Cruz Biotechnology EPCAM antibody (Santa Cruz, sc-66020) was used in flow cytometry on human samples at 1:25. Respir Res (2014) ncbi
mouse monoclonal (C-10)
  • western blot; human; fig 6
In order to develop a masked selection strategy to use during phage display selection, Santa Cruz Biotechnology EPCAM antibody (Santa, sc-25308) was used in western blot on human samples (fig 6). Mol Cell Proteomics (2014) ncbi
mouse monoclonal (VU-1D9)
  • immunocytochemistry; human
Santa Cruz Biotechnology EPCAM antibody (Santa Cruz Biotechnology, VU-1D9) was used in immunocytochemistry on human samples . J Immunol (2014) ncbi
Invitrogen
mouse monoclonal (1B7)
  • flow cytometry; human; loading ...; fig 3e, s4b
Invitrogen EPCAM antibody (EBioscience, 46-9326-42) was used in flow cytometry on human samples (fig 3e, s4b). Breast Cancer Res (2019) ncbi
mouse monoclonal (1B7)
Invitrogen EPCAM antibody (eBiosciences, 12-9326) was used . Cell (2018) ncbi
mouse monoclonal (MH99)
  • flow cytometry; human; loading ...; fig s2a
In order to describe a microfluidic western blot for an eight-plex protein panel for individual circulating tumor cells derived from estrogen receptor-positive breast cancer patients, Invitrogen EPCAM antibody (eBioscience, 53-8326-42) was used in flow cytometry on human samples (fig s2a). Nat Commun (2017) ncbi
mouse monoclonal (VU-1D9)
  • immunohistochemistry; human; 1:50; loading ...; fig 2c,3
In order to analyze the importance of canonical Hedgehog signaling within the primary cilia+ liver progenitor cell population in humans, Invitrogen EPCAM antibody (Thermo Scientific, MS-144-P) was used in immunohistochemistry on human samples at 1:50 (fig 2c,3). PLoS ONE (2017) ncbi
domestic rabbit polyclonal
  • immunoprecipitation; human; loading ...; fig 2d
  • immunohistochemistry; human; loading ...; fig 2b
  • western blot; human; loading ...; fig 1b
In order to test if HAI-2, matriptase, EpCAM, and claudin-7 are functionally linked in the intestine, Invitrogen EPCAM antibody (Life Technologies, PA5-19832) was used in immunoprecipitation on human samples (fig 2d), in immunohistochemistry on human samples (fig 2b) and in western blot on human samples (fig 1b). J Clin Invest (2017) ncbi
mouse monoclonal (VU-1D9)
  • flow cytometry; human; loading ...; tbl 1
In order to investigate somatic reprogramming of adult cells to induced pluripotent stem cells, Invitrogen EPCAM antibody (Thermo Fisher, A15755) was used in flow cytometry on human samples (tbl 1). J Vis Exp (2016) ncbi
mouse monoclonal (323/A3)
  • other; human; tbl 1
In order to study accurate affinity ranking of arrayed ligand-analyte interactions by an interpolation method, Invitrogen EPCAM antibody (Pierce, MA5-12436) was used in other on human samples (tbl 1). Anal Biochem (2016) ncbi
mouse monoclonal (Ber-EP4)
  • other; human; fig 1
In order to study human S100A10 in endometrial receptivity phenotype, Invitrogen EPCAM antibody (Invitrogen, BerEP4) was used in other on human samples (fig 1). Cell Adh Migr (2016) ncbi
mouse monoclonal (1B7)
  • flow cytometry; human; loading ...; fig 2b
In order to find that breast cancer stem cells isolated with CD44(+)CD24(-/lo)SSEA-3(+) or ESA(hi)PROCR(hi)SSEA-3(+) markers have higher tumorigenicity than those with conventional markers, Invitrogen EPCAM antibody (eBioscience, 1B7) was used in flow cytometry on human samples (fig 2b). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (MOC-31)
  • immunohistochemistry - paraffin section; human; 1:50
In order to study the prognostic effect of Keratin 19 expression on survival of patients with human hepatocellular carcinoma, Invitrogen EPCAM antibody (Neomarkers, MOC31) was used in immunohistochemistry - paraffin section on human samples at 1:50. Eur J Gastroenterol Hepatol (2015) ncbi
mouse monoclonal (VU-1D9)
  • western blot; human; 1:1000
In order to develop an immunofluorescence method to assess MCT1 and MCT4 in circulating tumor cells and as them as biomarkers of AZD3965 in cancer patients, Invitrogen EPCAM antibody (Thermo Scientific, MS-144-P) was used in western blot on human samples at 1:1000. BMC Cancer (2015) ncbi
mouse monoclonal (1B7)
  • flow cytometry; human; fig 5
In order to describe the phenotype and functional potential of metastatic differentiated thyroid cancer-associated PD-1 positive T cells, Invitrogen EPCAM antibody (eBioscience, IB7) was used in flow cytometry on human samples (fig 5). Cancer Immunol Res (2015) ncbi
mouse monoclonal (VU-1D9)
  • immunocytochemistry; human; 750 ng/ml
Invitrogen EPCAM antibody (Life Technologies, VU-1D9) was used in immunocytochemistry on human samples at 750 ng/ml. Cytometry A (2014) ncbi
mouse monoclonal (VU-1D9)
  • immunohistochemistry - paraffin section; human; 1:100
  • immunocytochemistry; human; 1:100
In order to investigate epithelial to mesenchymal transition during metastasis of pancreatic cancer, Invitrogen EPCAM antibody (Labvision, MS-144) was used in immunohistochemistry - paraffin section on human samples at 1:100 and in immunocytochemistry on human samples at 1:100. Br J Cancer (2012) ncbi
mouse monoclonal (MOC-31)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1b
In order to study EpCAM overexpression in uterine serous papillary carcinoma and the implications for monoclonal antibody therapy, Invitrogen EPCAM antibody (Neomarkers, MOC-31) was used in immunohistochemistry - paraffin section on human samples (fig 1b). Mol Cancer Ther (2010) ncbi
mouse monoclonal (323/A3)
  • immunohistochemistry; human; tbl 2
In order to identify key matrix components required for ex vivo maintenance of human hepatic progenitors, Invitrogen EPCAM antibody (NeoMarker, MS-181-P1) was used in immunohistochemistry on human samples (tbl 2). Tissue Eng Part A (2008) ncbi
Bio-Rad
mouse monoclonal (VU-1D9)
  • flow cytometry; human; 1:800; fig s6
Bio-Rad EPCAM antibody (AbD Serotec, VU-1D9) was used in flow cytometry on human samples at 1:800 (fig s6). Nat Commun (2016) ncbi
mouse monoclonal (VU-1D9)
  • flow cytometry; human
Bio-Rad EPCAM antibody (AbD Serotec, MCA1870F) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
R&D Systems
domestic goat polyclonal
  • immunocytochemistry; human; 1:50; loading ...; fig 1c
R&D Systems EPCAM antibody (R&D Systems, AF960) was used in immunocytochemistry on human samples at 1:50 (fig 1c). Nat Commun (2021) ncbi
Abnova
mouse monoclonal (SPM134)
  • other; human; tbl 1
In order to study accurate affinity ranking of arrayed ligand-analyte interactions by an interpolation method, Abnova EPCAM antibody (Abnova, MAB12106) was used in other on human samples (tbl 1). Anal Biochem (2016) ncbi
OriGene
mouse monoclonal (OTI1H9)
  • immunohistochemistry; human; 1:150; loading ...; fig 1b
OriGene EPCAM antibody (OriGene, TA506627) was used in immunohistochemistry on human samples at 1:150 (fig 1b). J Breast Cancer (2015) ncbi
Novus Biologicals
mouse monoclonal (VU-1D9)
  • immunocytochemistry; human; fig 2a
Novus Biologicals EPCAM antibody (Novus Biological, VU1D9) was used in immunocytochemistry on human samples (fig 2a). BMC Cancer (2016) ncbi
Cell Signaling Technology
mouse monoclonal (VU1D9)
  • western blot; human; 1:1000; loading ...; fig 7
Cell Signaling Technology EPCAM antibody (Cell signaling Technology, VU1D9) was used in western blot on human samples at 1:1000 (fig 7). elife (2020) ncbi
domestic rabbit monoclonal (D1B3)
  • western blot; human; 1:1000; loading ...; fig 8h
Cell Signaling Technology EPCAM antibody (Cell Signaling, D1B3) was used in western blot on human samples at 1:1000 (fig 8h). elife (2020) ncbi
mouse monoclonal (VU1D9)
  • western blot; human; loading ...; fig 1d, s2d, s2e, s2f
Cell Signaling Technology EPCAM antibody (Cell Signaling, 2929) was used in western blot on human samples (fig 1d, s2d, s2e, s2f). Mol Cancer (2019) ncbi
mouse monoclonal (VU1D9)
  • immunohistochemistry; human; 1:1000; loading ...; fig 1b
  • western blot; human; 1:1000; loading ...; fig 1a
Cell Signaling Technology EPCAM antibody (Cell Signaling Technology, 2929) was used in immunohistochemistry on human samples at 1:1000 (fig 1b) and in western blot on human samples at 1:1000 (fig 1a). Biol Open (2019) ncbi
mouse monoclonal (VU1D9)
  • western blot; human; fig s5b
Cell Signaling Technology EPCAM antibody (Cell Signaling, 2929) was used in western blot on human samples (fig s5b). Cell Chem Biol (2019) ncbi
mouse monoclonal (VU1D9)
  • western blot; human; loading ...; fig 3b
Cell Signaling Technology EPCAM antibody (Cell Signaling, VU1D9) was used in western blot on human samples (fig 3b). Mol Cell Biol (2017) ncbi
mouse monoclonal (VU1D9)
  • western blot; mouse; loading ...; fig 2c
  • western blot; human; loading ...; fig 2a
Cell Signaling Technology EPCAM antibody (CST, 5447) was used in western blot on mouse samples (fig 2c) and in western blot on human samples (fig 2a). Sci Rep (2017) ncbi
domestic rabbit monoclonal (D1B3)
  • western blot; human; 1:1000; fig 2c
Cell Signaling Technology EPCAM antibody (Cell signaling, 2626) was used in western blot on human samples at 1:1000 (fig 2c). Mol Ther (2017) ncbi
mouse monoclonal (VU1D9)
  • flow cytometry; human; loading ...; fig 1a
  • immunocytochemistry; human
Cell Signaling Technology EPCAM antibody (Cell Signaling Technology, VU1D9) was used in flow cytometry on human samples (fig 1a) and in immunocytochemistry on human samples . Nature (2016) ncbi
mouse monoclonal (VU1D9)
  • flow cytometry; human; fig s3
Cell Signaling Technology EPCAM antibody (Cell Signaling Tech, 5447) was used in flow cytometry on human samples (fig s3). Nat Commun (2016) ncbi
mouse monoclonal (VU1D9)
  • flow cytometry; human; loading ...; fig 5a
In order to develop a cell sorting technique for use with a suspended microchannel resonator that measures the biophysical characteristics of a single cell, Cell Signaling Technology EPCAM antibody (Cell Signaling, 7319) was used in flow cytometry on human samples (fig 5a). Integr Biol (Camb) (2016) ncbi
mouse monoclonal (VU1D9)
  • western blot; human; loading ...; fig 2b
Cell Signaling Technology EPCAM antibody (Cell Signaling, 2929) was used in western blot on human samples (fig 2b). Oncol Lett (2016) ncbi
mouse monoclonal (VU1D9)
  • immunocytochemistry; human; fig 5
Cell Signaling Technology EPCAM antibody (Cell Signaling Technologies, 5198S) was used in immunocytochemistry on human samples (fig 5). Sci Rep (2015) ncbi
mouse monoclonal (VU1D9)
  • immunocytochemistry; human; fig 4
Cell Signaling Technology EPCAM antibody (Cell Signaling, VU1D9) was used in immunocytochemistry on human samples (fig 4). J Biol Chem (2015) ncbi
mouse monoclonal (VU1D9)
  • western blot; human
Cell Signaling Technology EPCAM antibody (CST, #2929) was used in western blot on human samples . Oncol Rep (2015) ncbi
mouse monoclonal (VU1D9)
  • western blot; mouse; 1:2000; fig 5a
Cell Signaling Technology EPCAM antibody (Cell Signaling, 2929) was used in western blot on mouse samples at 1:2000 (fig 5a). Nat Commun (2015) ncbi
domestic rabbit monoclonal (D1B3)
  • western blot; human
In order to study the relationship between nuclear LASP-1 and the epigenetic machinery in breast cancer, Cell Signaling Technology EPCAM antibody (cst, 2626S) was used in western blot on human samples . Oncogene (2016) ncbi
mouse monoclonal (VU1D9)
  • flow cytometry; human; loading ...; fig S3
Cell Signaling Technology EPCAM antibody (Cell Signaling Technology, 2929) was used in flow cytometry on human samples (fig S3). Oncotarget (2015) ncbi
domestic rabbit monoclonal (D1B3)
  • flow cytometry; human
Cell Signaling Technology EPCAM antibody (Cell Signaling Technology, 2626) was used in flow cytometry on human samples . Clin Cancer Res (2015) ncbi
mouse monoclonal (VU1D9)
  • western blot; human; fig 2
Cell Signaling Technology EPCAM antibody (Cell Signaling, 2929) was used in western blot on human samples (fig 2). Oncotarget (2015) ncbi
mouse monoclonal (VU1D9)
  • immunohistochemistry; human; 1:500
Cell Signaling Technology EPCAM antibody (Cell Signalling, VU1D9) was used in immunohistochemistry on human samples at 1:500. Gut (2015) ncbi
mouse monoclonal (VU1D9)
  • immunohistochemistry - paraffin section; mouse; 1:100
Cell Signaling Technology EPCAM antibody (Cell Signaling, 2929) was used in immunohistochemistry - paraffin section on mouse samples at 1:100. Nat Genet (2013) ncbi
BD Biosciences
mouse monoclonal (EBA-1)
  • flow cytometry; human; 1:250; loading ...; fig 2a
BD Biosciences EPCAM antibody (BD Biosciences, 563181) was used in flow cytometry on human samples at 1:250 (fig 2a). Nat Commun (2021) ncbi
mouse monoclonal (EBA-1)
  • flow cytometry; human; 1:20; loading ...; fig 2d
BD Biosciences EPCAM antibody (BD, EBA-1) was used in flow cytometry on human samples at 1:20 (fig 2d). elife (2019) ncbi
mouse monoclonal (EBA-1)
  • flow cytometry; human; loading ...; fig 6a
BD Biosciences EPCAM antibody (BD, EBA-1) was used in flow cytometry on human samples (fig 6a). Front Immunol (2018) ncbi
mouse monoclonal (EBA-1)
  • flow cytometry; human; 1:20; loading ...; fig 1e
BD Biosciences EPCAM antibody (BD Biosciences, 347199) was used in flow cytometry on human samples at 1:20 (fig 1e). J Pathol (2017) ncbi
mouse monoclonal (EBA-1)
  • flow cytometry; human; fig s1a
In order to find a role for IL-4 in promoting breast cancer aggressiveness, BD Biosciences EPCAM antibody (BD Biosciences, EBA-1) was used in flow cytometry on human samples (fig s1a). Cancer Res (2017) ncbi
mouse monoclonal (EBA-1)
  • flow cytometry; human; tbl 1
In order to compare methods of isolating skin mononuclear phagocytes, BD Biosciences EPCAM antibody (Becton Dickinson, EBA-1) was used in flow cytometry on human samples (tbl 1). J Leukoc Biol (2017) ncbi
mouse monoclonal (EBA-1)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BD Biosciences EPCAM antibody (BD Biosciences, EBA-1) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (EBA-1)
  • flow cytometry; human; 1:100; loading ...; fig 2a
In order to report that cell density deterministically alters anteroposterior patterning of primitive streak-like priming, BD Biosciences EPCAM antibody (BD biosciences, EBA-1) was used in flow cytometry on human samples at 1:100 (fig 2a). Nat Commun (2016) ncbi
mouse monoclonal (EBA-1)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate the role of galectin-3 in gastrointestinal cancer stem cells, BD Biosciences EPCAM antibody (bd, 347197) was used in flow cytometry on human samples (fig 1a). Cell Death Dis (2016) ncbi
mouse monoclonal (EBA-1)
  • flow cytometry; human; loading ...; fig 1e
BD Biosciences EPCAM antibody (BD, EBA-1) was used in flow cytometry on human samples (fig 1e). Oncotarget (2016) ncbi
mouse monoclonal (EBA-1)
  • flow cytometry; human; loading ...; fig 4
In order to discuss the relationship between TGF-beta and MYC in basal subtype breast cancers, BD Biosciences EPCAM antibody (BD Biosciences, 347197) was used in flow cytometry on human samples (fig 4). Cancer Res (2016) ncbi
mouse monoclonal (EBA-1)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences EPCAM antibody (BD, 347198) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (EBA-1)
  • flow cytometry; human; fig s1
In order to analyze the DUSP family members and their differential roles in epithelial to mesenchymal transition and cancer stem cell regulation in breast cancer, BD Biosciences EPCAM antibody (BD Biosciences, 347199) was used in flow cytometry on human samples (fig s1). PLoS ONE (2016) ncbi
mouse monoclonal (EBA-1)
  • flow cytometry; human; fig 2,4
BD Biosciences EPCAM antibody (BD Biosciences, #347198) was used in flow cytometry on human samples (fig 2,4). Proteomics (2015) ncbi
mouse monoclonal (EBA-1)
  • flow cytometry; human; fig s5
In order to describe the use of CCR9 expression to create primary gastrointestinal tumors in immunodeficient mice by tail-vein injection, BD Biosciences EPCAM antibody (BD Pharmingen, 347197) was used in flow cytometry on human samples (fig s5). Nat Biotechnol (2015) ncbi
mouse monoclonal (EBA-1)
  • flow cytometry; human
BD Biosciences EPCAM antibody (BD Biosciences, 347197) was used in flow cytometry on human samples . J Clin Invest (2015) ncbi
mouse monoclonal (EBA-1)
  • flow cytometry; human
BD Biosciences EPCAM antibody (BD, 347200) was used in flow cytometry on human samples . Nucleic Acids Res (2015) ncbi
mouse monoclonal (EBA-1)
  • flow cytometry; human
In order to generate and assess primary pancreatic adenocarcinoma cell lines for colony forming capacity, tumourigenicity, expression of known cancer cell surface markers and cancer stem-like characteristics, BD Biosciences EPCAM antibody (Becton Dickinson, clone EBA-1) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (EBA-1)
  • immunohistochemistry - frozen section; human; 1:100
In order to develop a protocol for the efficient generation of airway and lung epithelial cells from human pluripotent stem cells, BD Biosciences EPCAM antibody (BD, 347200) was used in immunohistochemistry - frozen section on human samples at 1:100. Nat Biotechnol (2014) ncbi
Articles Reviewed
  1. Jung S, Kim D, Choi Y, Kim S, Park H, Lee H, et al. Contribution of p53 in sensitivity to EGFR tyrosine kinase inhibitors in non-small cell lung cancer. Sci Rep. 2021;11:19667 pubmed publisher
  2. Malenica I, Adam J, Corgnac S, Mezquita L, Auclin E, Damei I, et al. Integrin-αV-mediated activation of TGF-β regulates anti-tumour CD8 T cell immunity and response to PD-1 blockade. Nat Commun. 2021;12:5209 pubmed publisher
  3. Zhao Y, Li Z, Zhu Y, Fu J, Zhao X, Zhang Y, et al. Single-Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids. Adv Sci (Weinh). 2021;8:e2003897 pubmed publisher
  4. Barthet V, Brucoli M, Ladds M, Nössing C, Kiourtis C, Baudot A, et al. Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver. Sci Adv. 2021;7: pubmed publisher
  5. Sacchetti A, Teeuwssen M, Verhagen M, Joosten R, Xu T, Stabile R, et al. Phenotypic plasticity underlies local invasion and distant metastasis in colon cancer. elife. 2021;10: pubmed publisher
  6. Hendley A, Rao A, Leonhardt L, Ashe S, Smith J, Giacometti S, et al. Single-cell transcriptome analysis defines heterogeneity of the murine pancreatic ductal tree. elife. 2021;10: pubmed publisher
  7. Sbiera I, Kircher S, Altieri B, Fassnacht M, Kroiss M, Sbiera S. Epithelial and Mesenchymal Markers in Adrenocortical Tissues: How Mesenchymal Are Adrenocortical Tissues?. Cancers (Basel). 2021;13: pubmed publisher
  8. Della Chiara G, Gervasoni F, Fakiola M, Godano C, D Oria C, Azzolin L, et al. Epigenomic landscape of human colorectal cancer unveils an aberrant core of pan-cancer enhancers orchestrated by YAP/TAZ. Nat Commun. 2021;12:2340 pubmed publisher
  9. Fayad R, Rojas M, Partisani M, Finetti P, Dib S, Abélanet S, et al. EFA6B regulates a stop signal for collective invasion in breast cancer. Nat Commun. 2021;12:2198 pubmed publisher
  10. Pavlovic N, Calitz C, Thanapirom K, Mazza G, Rombouts K, Gerwins P, et al. Inhibiting IRE1α-endonuclease activity decreases tumor burden in a mouse model for hepatocellular carcinoma. elife. 2020;9: pubmed publisher
  11. Huang Y, Liang C, Ritz D, Coelho R, Septiadi D, Estermann M, et al. Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis. elife. 2020;9: pubmed publisher
  12. Oliemuller E, Newman R, Tsang S, Foo S, Muirhead G, Noor F, et al. SOX11 promotes epithelial/mesenchymal hybrid state and alters tropism of invasive breast cancer cells. elife. 2020;9: pubmed publisher
  13. Steins A, van Mackelenbergh M, van der Zalm A, Klaassen R, Serrels B, Goris S, et al. High-grade mesenchymal pancreatic ductal adenocarcinoma drives stromal deactivation through CSF-1. EMBO Rep. 2020;21:e48780 pubmed publisher
  14. Calandrini C, Schutgens F, Oka R, Margaritis T, Candelli T, Mathijsen L, et al. An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity. Nat Commun. 2020;11:1310 pubmed publisher
  15. Nayakawde N, Methe K, Banerjee D, Berg M, Premaratne G, Olausson M. In Vitro Regeneration of Decellularized Pig Esophagus Using Human Amniotic Stem Cells. Biores Open Access. 2020;9:22-36 pubmed publisher
  16. Carpinelli M, de Vries M, Auden A, Butt T, Deng Z, Partridge D, et al. Inactivation of Zeb1 in GRHL2-deficient mouse embryos rescues mid-gestation viability and secondary palate closure. Dis Model Mech. 2020;13: pubmed publisher
  17. Vijayaraj P, Minasyan A, Durra A, Karumbayaram S, Mehrabi M, Aros C, et al. Modeling Progressive Fibrosis with Pluripotent Stem Cells Identifies an Anti-fibrotic Small Molecule. Cell Rep. 2019;29:3488-3505.e9 pubmed publisher
  18. Lin Q, Chen X, Meng F, Ogawa K, Li M, Song R, et al. ASPH-notch Axis guided Exosomal delivery of Prometastatic Secretome renders breast Cancer multi-organ metastasis. Mol Cancer. 2019;18:156 pubmed publisher
  19. Ramachandran P, Dobie R, Wilson Kanamori J, Dora E, Henderson B, Luu N, et al. Resolving the fibrotic niche of human liver cirrhosis at single-cell level. Nature. 2019;575:512-518 pubmed publisher
  20. Yang Y, Liu S, Lei Z, Chen G, Huang L, Yang F, et al. Circular RNA profile in liver tissue of EpCAM knockout mice. Int J Mol Med. 2019;44:1063-1077 pubmed publisher
  21. Gal H, Lysenko M, Stroganov S, Vadai E, Youssef S, Tzadikevitch Geffen K, et al. Molecular pathways of senescence regulate placental structure and function. EMBO J. 2019;38:e100849 pubmed publisher
  22. Katsuda T, Matsuzaki J, Yamaguchi T, Yamada Y, Prieto Vila M, Hosaka K, et al. Generation of human hepatic progenitor cells with regenerative and metabolic capacities from primary hepatocytes. elife. 2019;8: pubmed publisher
  23. Barkal A, Brewer R, Markovic M, Kowarsky M, Barkal S, Zaro B, et al. CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature. 2019;572:392-396 pubmed publisher
  24. Segal J, Kent D, Wesche D, Ng S, Serra M, Oulès B, et al. Single cell analysis of human foetal liver captures the transcriptional profile of hepatobiliary hybrid progenitors. Nat Commun. 2019;10:3350 pubmed publisher
  25. Vazquez Iglesias L, Barcia Castro L, Rodríguez Quiroga M, Páez de la Cadena M, Rodríguez Berrocal J, Cordero O. Surface expression marker profile in colon cancer cell lines and sphere-derived cells suggests complexity in CD26+ cancer stem cells subsets. Biol Open. 2019;8: pubmed publisher
  26. McGinnis C, Patterson D, Winkler J, Conrad D, Hein M, Srivastava V, et al. MULTI-seq: sample multiplexing for single-cell RNA sequencing using lipid-tagged indices. Nat Methods. 2019;: pubmed publisher
  27. Dangaj D, Bruand M, Grimm A, Ronet C, Barras D, Duttagupta P, et al. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Cancer Cell. 2019;35:885-900.e10 pubmed publisher
  28. Sabol R, Bowles A, Côté A, Wise R, O Donnell B, Matossian M, et al. Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models. Breast Cancer Res. 2019;21:67 pubmed publisher
  29. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  30. Frank A, Ebersberger S, Fink A, Lampe S, Weigert A, Schmid T, et al. Apoptotic tumor cell-derived microRNA-375 uses CD36 to alter the tumor-associated macrophage phenotype. Nat Commun. 2019;10:1135 pubmed publisher
  31. Ludwig L, Lareau C, Ulirsch J, Christian E, Muus C, Li L, et al. Lineage Tracing in Humans Enabled by Mitochondrial Mutations and Single-Cell Genomics. Cell. 2019;176:1325-1339.e22 pubmed publisher
  32. Gao Q, Yang Z, Xu S, Li X, Yang X, Jin P, et al. Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer. J Exp Med. 2019;216:688-703 pubmed publisher
  33. Montel Hagen A, Seet C, Li S, Chick B, Zhu Y, Chang P, et al. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells. Cell Stem Cell. 2019;24:376-389.e8 pubmed publisher
  34. LI Y, Du L, Wang J, Vega R, Lee T, Miao Y, et al. Allosteric Inhibition of Ubiquitin-like Modifications by a Class of Inhibitor of SUMO-Activating Enzyme. Cell Chem Biol. 2019;26:278-288.e6 pubmed publisher
  35. Zhang C, Wang Y. Metformin attenuates cells stemness and epithelial‑mesenchymal transition in colorectal cancer cells by inhibiting the Wnt3a/β‑catenin pathway. Mol Med Rep. 2019;19:1203-1209 pubmed publisher
  36. Tang Z, Ding Y, Shen Q, Zhang C, Li J, Nazar M, et al. KIAA1199 promotes invasion and migration in non-small-cell lung cancer (NSCLC) via PI3K-Akt mediated EMT. J Mol Med (Berl). 2019;97:127-140 pubmed publisher
  37. Kinchen J, Chen H, Parikh K, Antanaviciute A, Jagielowicz M, Fawkner Corbett D, et al. Structural Remodeling of the Human Colonic Mesenchyme in Inflammatory Bowel Disease. Cell. 2018;175:372-386.e17 pubmed publisher
  38. Cooper G, Ostridge K, Khakoo S, Wilkinson T, Staples K. Human CD49a+ Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus. Front Immunol. 2018;9:1671 pubmed publisher
  39. Casey A, Sinha A, Singhania R, Livingstone J, Waterhouse P, Tharmapalan P, et al. Mammary molecular portraits reveal lineage-specific features and progenitor cell vulnerabilities. J Cell Biol. 2018;217:2951-2974 pubmed publisher
  40. Peranzoni E, Lemoine J, Vimeux L, Feuillet V, Barrin S, Kantari Mimoun C, et al. Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment. Proc Natl Acad Sci U S A. 2018;115:E4041-E4050 pubmed publisher
  41. Gao Y, Wilson G, Bozaoglu K, Elefanty A, Stanley E, Dottori M, et al. Generation of RAB39B knockout isogenic human embryonic stem cell lines to model RAB39B-mediated Parkinson's disease. Stem Cell Res. 2018;28:161-164 pubmed publisher
  42. Su S, Chen J, Yao H, Liu J, Yu S, Lao L, et al. CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness. Cell. 2018;172:841-856.e16 pubmed publisher
  43. Paikari A, D Belair C, Saw D, Blelloch R. The eutheria-specific miR-290 cluster modulates placental growth and maternal-fetal transport. Development. 2017;144:3731-3743 pubmed publisher
  44. Oliemuller E, Kogata N, Bland P, Kriplani D, Daley F, Haider S, et al. SOX11 promotes invasive growth and ductal carcinoma in situ progression. J Pathol. 2017;243:193-207 pubmed publisher
  45. Al Khalaf H, Amir M, Al Mohanna F, Tulbah A, Al Sayed A, Aboussekhra A. Obesity and p16INK4A Downregulation Activate Breast Adipocytes and Promote Their Protumorigenicity. Mol Cell Biol. 2017;37: pubmed publisher
  46. Valanejad L, Lewis K, Wright M, Jiang Y, D Souza A, Karns R, et al. FXR-Gankyrin axis is involved in development of pediatric liver cancer. Carcinogenesis. 2017;38:738-747 pubmed publisher
  47. Smith T, Moffett H, Stephan S, Opel C, Dumigan A, Jiang X, et al. Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors. J Clin Invest. 2017;127:2176-2191 pubmed publisher
  48. Gaggianesi M, Turdo A, Chinnici A, Lipari E, Apuzzo T, Benfante A, et al. IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition. Cancer Res. 2017;77:3268-3279 pubmed publisher
  49. Deivendran S, Marzook H, Santhoshkumar T, Kumar R, Pillai M. Metastasis-associated protein 1 is an upstream regulator of DNMT3a and stimulator of insulin-growth factor binding protein-3 in breast cancer. Sci Rep. 2017;7:44225 pubmed publisher
  50. McCauley K, Hawkins F, Serra M, Thomas D, JACOB A, Kotton D. Efficient Derivation of Functional Human Airway Epithelium from Pluripotent Stem Cells via Temporal Regulation of Wnt Signaling. Cell Stem Cell. 2017;20:844-857.e6 pubmed publisher
  51. Sinkala E, Sollier Christen E, Renier C, Rosàs Canyelles E, Che J, Heirich K, et al. Profiling protein expression in circulating tumour cells using microfluidic western blotting. Nat Commun. 2017;8:14622 pubmed publisher
  52. Keckesova Z, Donaher J, De Cock J, Freinkman E, Lingrell S, Bachovchin D, et al. LACTB is a tumour suppressor that modulates lipid metabolism and cell state. Nature. 2017;543:681-686 pubmed publisher
  53. Botting R, Bertram K, Baharlou H, Sandgren K, Fletcher J, Rhodes J, et al. Phenotypic and functional consequences of different isolation protocols on skin mononuclear phagocytes. J Leukoc Biol. 2017;101:1393-1403 pubmed publisher
  54. Grzelak C, Sigglekow N, Tirnitz Parker J, Hamson E, Warren A, Maneck B, et al. Widespread GLI expression but limited canonical hedgehog signaling restricted to the ductular reaction in human chronic liver disease. PLoS ONE. 2017;12:e0171480 pubmed publisher
  55. Beltrami C, Besnier M, Shantikumar S, Shearn A, Rajakaruna C, Laftah A, et al. Human Pericardial Fluid Contains Exosomes Enriched with Cardiovascular-Expressed MicroRNAs and Promotes Therapeutic Angiogenesis. Mol Ther. 2017;25:679-693 pubmed publisher
  56. Kuan I, Liang K, Wang Y, Kuo T, Meir Y, Wu S, et al. EpEX/EpCAM and Oct4 or Klf4 alone are sufficient to generate induced pluripotent stem cells through STAT3 and HIF2α. Sci Rep. 2017;7:41852 pubmed publisher
  57. Fasano M, Della Corte C, Vicidomini G, Scotti V, Rambaldi P, Fiorelli A, et al. Small bowel metastasis from pancreatic cancer in a long-term survival patient with synchronous advanced malignant pleural mesothelioma: A case report and literature review. Oncol Lett. 2016;12:4505-4509 pubmed publisher
  58. Ertsås H, Nolan G, Labarge M, Lorens J. Microsphere cytometry to interrogate microenvironment-dependent cell signaling. Integr Biol (Camb). 2017;9:123-134 pubmed publisher
  59. Lango Chavarría M, Chimal Ramírez G, Ruiz Tachiquín M, Espinoza Sánchez N, Suárez Arriaga M, Fuentes Pananá E. A 22q11.2 amplification in the region encoding microRNA-650 correlates with the epithelial to mesenchymal transition in breast cancer primary cultures of Mexican patients. Int J Oncol. 2017;50:432-440 pubmed publisher
  60. Wu C, Feng X, Lu M, Morimura S, Udey M. Matriptase-mediated cleavage of EpCAM destabilizes claudins and dysregulates intestinal epithelial homeostasis. J Clin Invest. 2017;127:623-634 pubmed publisher
  61. Britschgi A, Duss S, Kim S, Couto J, Brinkhaus H, Koren S, et al. The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα. Nature. 2017;541:541-545 pubmed publisher
  62. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  63. Kempf H, Olmer R, Haase A, Franke A, Bolesani E, Schwanke K, et al. Bulk cell density and Wnt/TGFbeta signalling regulate mesendodermal patterning of human pluripotent stem cells. Nat Commun. 2016;7:13602 pubmed publisher
  64. Ding S, Mooney N, Li B, Kelly M, Feng N, Loktev A, et al. Comparative Proteomics Reveals Strain-Specific β-TrCP Degradation via Rotavirus NSP1 Hijacking a Host Cullin-3-Rbx1 Complex. PLoS Pathog. 2016;12:e1005929 pubmed publisher
  65. Jordan N, Bardia A, Wittner B, Benes C, Ligorio M, Zheng Y, et al. HER2 expression identifies dynamic functional states within circulating breast cancer cells. Nature. 2016;537:102-106 pubmed publisher
  66. Nicolazzo C, Raimondi C, Mancini M, Caponnetto S, Gradilone A, Gandini O, et al. Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab. Sci Rep. 2016;6:31726 pubmed publisher
  67. Ilmer M, Mazurek N, Byrd J, Ramirez K, Hafley M, Alt E, et al. Cell surface galectin-3 defines a subset of chemoresistant gastrointestinal tumor-initiating cancer cells with heightened stem cell characteristics. Cell Death Dis. 2016;7:e2337 pubmed publisher
  68. Quintanilla R, Asprer J, Sylakowski K, Lakshmipathy U. Kinetic Measurement and Real Time Visualization of Somatic Reprogramming. J Vis Exp. 2016;: pubmed publisher
  69. Du L, LI Y, Fakih M, Wiatrek R, Duldulao M, Chen Z, et al. Role of SUMO activating enzyme in cancer stem cell maintenance and self-renewal. Nat Commun. 2016;7:12326 pubmed publisher
  70. Pailler E, Oulhen M, Billiot F, Galland A, Auger N, Faugeroux V, et al. Method for semi-automated microscopy of filtration-enriched circulating tumor cells. BMC Cancer. 2016;16:477 pubmed publisher
  71. Bloom J, McNeel D. SSX2 regulates focal adhesion but does not drive the epithelial to mesenchymal transition in prostate cancer. Oncotarget. 2016;7:50997-51011 pubmed publisher
  72. Cichon M, Moruzzi M, Shqau T, Miller E, Mehner C, Ethier S, et al. MYC Is a Crucial Mediator of TGF?-Induced Invasion in Basal Breast Cancer. Cancer Res. 2016;76:3520-30 pubmed publisher
  73. Thakkar A, Wang B, Picon Ruiz M, Buchwald P, Ince T. Vitamin D and androgen receptor-targeted therapy for triple-negative breast cancer. Breast Cancer Res Treat. 2016;157:77-90 pubmed publisher
  74. Kuo C, Thompson A, Gallina M, Ye F, Johnson E, Sun W, et al. Optical painting and fluorescence activated sorting of single adherent cells labelled with photoswitchable Pdots. Nat Commun. 2016;7:11468 pubmed publisher
  75. Shaw Bagnall J, Byun S, Miyamoto D, Kang J, Maheswaran S, Stott S, et al. Deformability-based cell selection with downstream immunofluorescence analysis. Integr Biol (Camb). 2016;8:654-64 pubmed publisher
  76. Park S, Kim J, Kim N, Yang K, Shim J, Heo K. Estradiol, TGF-?1 and hypoxia promote breast cancer stemness and EMT-mediated breast cancer migration. Oncol Lett. 2016;11:1895-1902 pubmed
  77. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  78. Haraguchi T, Kondo M, Uchikawa R, Kobayashi K, Hiramatsu H, Kobayashi K, et al. Dynamics and plasticity of the epithelial to mesenchymal transition induced by miR-200 family inhibition. Sci Rep. 2016;6:21117 pubmed publisher
  79. Schasfoort R, Andree K, van der Velde N, van der Kooi A, Stojanović I, Terstappen L. Interpolation method for accurate affinity ranking of arrayed ligand-analyte interactions. Anal Biochem. 2016;500:21-3 pubmed publisher
  80. Boulding T, Wu F, McCuaig R, Dunn J, Sutton C, Hardy K, et al. Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer. PLoS ONE. 2016;11:e0148065 pubmed publisher
  81. Wang X, Jung Y, Jun S, Lee S, Wang W, Schneider A, et al. PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness. Nat Commun. 2016;7:10633 pubmed publisher
  82. Bissonnette L, Drissennek L, Antoine Y, Tiers L, Hirtz C, Lehmann S, et al. Human S100A10 plays a crucial role in the acquisition of the endometrial receptivity phenotype. Cell Adh Migr. 2016;10:282-98 pubmed publisher
  83. Guye P, Ebrahimkhani M, Kipniss N, Velazquez J, Schoenfeld E, Kiani S, et al. Genetically engineering self-organization of human pluripotent stem cells into a liver bud-like tissue using Gata6. Nat Commun. 2016;7:10243 pubmed publisher
  84. Shaw Bagnall J, Byun S, Begum S, Miyamoto D, Hecht V, Maheswaran S, et al. Deformability of Tumor Cells versus Blood Cells. Sci Rep. 2015;5:18542 pubmed publisher
  85. Cheung S, Chuang P, Huang H, Hwang Verslues W, Cho C, Yang W, et al. Stage-specific embryonic antigen-3 (SSEA-3) and β3GalT5 are cancer specific and significant markers for breast cancer stem cells. Proc Natl Acad Sci U S A. 2016;113:960-5 pubmed publisher
  86. Fraveto A, Cardinale V, Bragazzi M, Giuliante F, De Rose A, Grazi G, et al. Sensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents: A Study on Primary Cell Cultures. PLoS ONE. 2015;10:e0142124 pubmed publisher
  87. Fridriksdottir A, Kim J, Villadsen R, Klitgaard M, Hopkinson B, Petersen O, et al. Propagation of oestrogen receptor-positive and oestrogen-responsive normal human breast cells in culture. Nat Commun. 2015;6:8786 pubmed publisher
  88. Hoshino A, Costa Silva B, Shen T, Rodrigues G, Hashimoto A, Tesic Mark M, et al. Tumour exosome integrins determine organotropic metastasis. Nature. 2015;527:329-35 pubmed publisher
  89. Wands A, Fujita A, McCombs J, Cervin J, Dedic B, Rodriguez A, et al. Fucosylation and protein glycosylation create functional receptors for cholera toxin. elife. 2015;4:e09545 pubmed publisher
  90. Ye F, Qiu Y, Li L, Yang L, Cheng F, Zhang H, et al. The Presence of EpCAM(-)/CD49f(+) Cells in Breast Cancer Is Associated with a Poor Clinical Outcome. J Breast Cancer. 2015;18:242-8 pubmed publisher
  91. Izumi D, Ishimoto T, Miyake K, Sugihara H, Eto K, Sawayama H, et al. CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer. Int J Cancer. 2016;138:1207-19 pubmed publisher
  92. Nie S, McDermott S, Deol Y, Tan Z, Wicha M, Lubman D. A quantitative proteomics analysis of MCF7 breast cancer stem and progenitor cell populations. Proteomics. 2015;15:3772-83 pubmed publisher
  93. Tsaktanis T, Kremling H, Pavšič M, von Stackelberg R, Mack B, Fukumori A, et al. Cleavage and cell adhesion properties of human epithelial cell adhesion molecule (HEPCAM). J Biol Chem. 2015;290:24574-91 pubmed publisher
  94. Morancho B, Martínez Barriocanal Ã, Villanueva J, Arribas J. Role of ADAM17 in the non-cell autonomous effects of oncogene-induced senescence. Breast Cancer Res. 2015;17:106 pubmed publisher
  95. Liu J, Brzeszczynska J, Samuel K, Black J, Palakkan A, Anderson R, et al. Efficient episomal reprogramming of blood mononuclear cells and differentiation to hepatocytes with functional drug metabolism. Exp Cell Res. 2015;338:203-13 pubmed publisher
  96. Lu W, Bird T, Boulter L, Tsuchiya A, Cole A, Hay T, et al. Hepatic progenitor cells of biliary origin with liver repopulation capacity. Nat Cell Biol. 2015;17:971-983 pubmed publisher
  97. Nagahara T, Shiraha H, Sawahara H, Uchida D, Takeuchi Y, Iwamuro M, et al. Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells. Oncol Rep. 2015;34:1169-77 pubmed publisher
  98. Abreu Vieira G, Fischer A, Mattsson C, de Jong J, Shabalina I, Ryden M, et al. Cidea improves the metabolic profile through expansion of adipose tissue. Nat Commun. 2015;6:7433 pubmed publisher
  99. Thieme R, Kurz S, Kolb M, Debebe T, Holtze S, Morhart M, et al. Analysis of Alpha-2 Macroglobulin from the Long-Lived and Cancer-Resistant Naked Mole-Rat and Human Plasma. PLoS ONE. 2015;10:e0130470 pubmed publisher
  100. Durrans A, Gao D, Gupta R, Fischer K, Choi H, El Rayes T, et al. Identification of Reprogrammed Myeloid Cell Transcriptomes in NSCLC. PLoS ONE. 2015;10:e0129123 pubmed publisher
  101. Fatourou E, Koskinas J, Karandrea D, Palaiologou M, Syminelaki T, Karanikolas M, et al. Keratin 19 protein expression is an independent predictor of survival in human hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2015;27:1094-102 pubmed publisher
  102. Chen H, Sun J, Huang Z, Hou H, Arcilla M, Rakhilin N, et al. Comprehensive models of human primary and metastatic colorectal tumors in immunodeficient and immunocompetent mice by chemokine targeting. Nat Biotechnol. 2015;33:656-60 pubmed publisher
  103. Duvall Noelle N, Karwandyar A, Richmond A, Raman D. LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex. Oncogene. 2016;35:1122-33 pubmed publisher
  104. Muhanna N, Mepham A, Mohamadi R, Chan H, Khan T, Akens M, et al. Nanoparticle-based sorting of circulating tumor cells by epithelial antigen expression during disease progression in an animal model. Nanomedicine. 2015;11:1613-20 pubmed publisher
  105. Kershaw S, Cummings J, Morris K, Tugwood J, Dive C. Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells. BMC Cancer. 2015;15:387 pubmed publisher
  106. Fan H, Zhang H, Pascuzzi P, Andrisani O. Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2. Oncogene. 2016;35:715-26 pubmed publisher
  107. Jørgensen M, Bæk R, Varming K. Potentials and capabilities of the Extracellular Vesicle (EV) Array. J Extracell Vesicles. 2015;4:26048 pubmed publisher
  108. Kishikawa T, Otsuka M, Tan P, Ohno M, Sun X, Yoshikawa T, et al. Decreased miR122 in hepatocellular carcinoma leads to chemoresistance with increased arginine. Oncotarget. 2015;6:8339-52 pubmed
  109. Severson J, Serracino H, Mateescu V, Raeburn C, McIntyre R, Sams S, et al. PD-1+Tim-3+ CD8+ T Lymphocytes Display Varied Degrees of Functional Exhaustion in Patients with Regionally Metastatic Differentiated Thyroid Cancer. Cancer Immunol Res. 2015;3:620-30 pubmed publisher
  110. Chen Y, Terajima M, Yang Y, Sun L, Ahn Y, Panková D, et al. Lysyl hydroxylase 2 induces a collagen cross-link switch in tumor stroma. J Clin Invest. 2015;125:1147-62 pubmed publisher
  111. Wong A, Chin S, Xia S, Garner J, Bear C, Rossant J. Efficient generation of functional CFTR-expressing airway epithelial cells from human pluripotent stem cells. Nat Protoc. 2015;10:363-81 pubmed publisher
  112. Stack G, Jones E, Marsden M, Stacey M, Snelgrove R, Lacaze P, et al. CD200 receptor restriction of myeloid cell responses antagonizes antiviral immunity and facilitates cytomegalovirus persistence within mucosal tissue. PLoS Pathog. 2015;11:e1004641 pubmed publisher
  113. Chiappetta G, Valentino T, Vitiello M, Pasquinelli R, Monaco M, Palma G, et al. PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration. Oncotarget. 2015;6:5310-23 pubmed
  114. Van de Laar E, Clifford M, Hasenoeder S, Kim B, Wang D, Lee S, et al. Cell surface marker profiling of human tracheal basal cells reveals distinct subpopulations, identifies MST1/MSP as a mitogenic signal, and identifies new biomarkers for lung squamous cell carcinomas. Respir Res. 2014;15:160 pubmed publisher
  115. Cuellar T, Barnes D, Nelson C, Tanguay J, Yu S, Wen X, et al. Systematic evaluation of antibody-mediated siRNA delivery using an industrial platform of THIOMAB-siRNA conjugates. Nucleic Acids Res. 2015;43:1189-203 pubmed publisher
  116. Yang Y, Otte A, Hass R. Human mesenchymal stroma/stem cells exchange membrane proteins and alter functionality during interaction with different tumor cell lines. Stem Cells Dev. 2015;24:1205-22 pubmed publisher
  117. Satelli A, Mitra A, Brownlee Z, Xia X, Bellister S, Overman M, et al. Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progression. Clin Cancer Res. 2015;21:899-906 pubmed publisher
  118. Krönig M, Walter M, Drendel V, Werner M, Jilg C, Richter A, et al. Cell type specific gene expression analysis of prostate needle biopsies resolves tumor tissue heterogeneity. Oncotarget. 2015;6:1302-14 pubmed
  119. Dong X, Lin Q, Aihara A, Li Y, Huang C, Chung W, et al. Aspartate β-Hydroxylase expression promotes a malignant pancreatic cellular phenotype. Oncotarget. 2015;6:1231-48 pubmed
  120. Orchard Webb D, Lee T, Cook G, Blair G. CUB domain containing protein 1 (CDCP1) modulates adhesion and motility in colon cancer cells. BMC Cancer. 2014;14:754 pubmed publisher
  121. Cai X, Dai Z, Reeves R, Caballero Benítez A, Duran K, Delrow J, et al. Autonomous stimulation of cancer cell plasticity by the human NKG2D lymphocyte receptor coexpressed with its ligands on cancer cells. PLoS ONE. 2014;9:e108942 pubmed publisher
  122. So J, Lin J, Wahler J, Liby K, Sporn M, Suh N. A synthetic triterpenoid CDDO-Im inhibits tumorsphere formation by regulating stem cell signaling pathways in triple-negative breast cancer. PLoS ONE. 2014;9:e107616 pubmed publisher
  123. Gao D, Vela I, Sboner A, Iaquinta P, Karthaus W, Gopalan A, et al. Organoid cultures derived from patients with advanced prostate cancer. Cell. 2014;159:176-187 pubmed publisher
  124. Wennerström A, Lothe I, Sandhu V, Kure E, Myklebost O, Munthe E. Generation and characterisation of novel pancreatic adenocarcinoma xenograft models and corresponding primary cell lines. PLoS ONE. 2014;9:e103873 pubmed publisher
  125. Dogan A, Demirci S, Sahin F. In vitro differentiation of human tooth germ stem cells into endothelial- and epithelial-like cells. Cell Biol Int. 2015;39:94-103 pubmed publisher
  126. Shah P, Herrera Loeza S, Sims C, Yeh J, Allbritton N. Small sample sorting of primary adherent cells by automated micropallet imaging and release. Cytometry A. 2014;85:642-9 pubmed publisher
  127. Gerlach K, Hwang Y, Nikolaev A, Atreya R, Dornhoff H, Steiner S, et al. TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat Immunol. 2014;15:676-86 pubmed publisher
  128. Morris K, Nofchissey R, Pinchuk I, Beswick E. Chronic macrophage migration inhibitory factor exposure induces mesenchymal epithelial transition and promotes gastric and colon cancers. PLoS ONE. 2014;9:e98656 pubmed publisher
  129. Petrakova O, Terskikh V, Chernioglo E, Ashapkin V, Bragin E, Shtratnikova V, et al. Comparative analysis reveals similarities between cultured submandibular salivary gland cells and liver progenitor cells. Springerplus. 2014;3:183 pubmed publisher
  130. Barbera M, Di Pietro M, Walker E, Brierley C, Macrae S, Simons B, et al. The human squamous oesophagus has widespread capacity for clonal expansion from cells at diverse stages of differentiation. Gut. 2015;64:11-9 pubmed publisher
  131. Morris K, Khan H, Ahmad A, Weston L, Nofchissey R, Pinchuk I, et al. G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration. Br J Cancer. 2014;110:1211-20 pubmed publisher
  132. Even Desrumeaux K, Nevoltris D, Lavaut M, Alim K, Borg J, Audebert S, et al. Masked selection: a straightforward and flexible approach for the selection of binders against specific epitopes and differentially expressed proteins by phage display. Mol Cell Proteomics. 2014;13:653-65 pubmed publisher
  133. Mueller J, McGeough M, Pena C, Sivagnanam M. Functional consequences of EpCam mutation in mice and men. Am J Physiol Gastrointest Liver Physiol. 2014;306:G278-88 pubmed publisher
  134. Huang S, Islam M, O NEILL J, Hu Z, Yang Y, Chen Y, et al. Efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat Biotechnol. 2014;32:84-91 pubmed publisher
  135. Volonté A, Di Tomaso T, Spinelli M, Todaro M, Sanvito F, Albarello L, et al. Cancer-initiating cells from colorectal cancer patients escape from T cell-mediated immunosurveillance in vitro through membrane-bound IL-4. J Immunol. 2014;192:523-32 pubmed publisher
  136. Nakanishi Y, Seno H, Fukuoka A, Ueo T, Yamaga Y, Maruno T, et al. Dclk1 distinguishes between tumor and normal stem cells in the intestine. Nat Genet. 2013;45:98-103 pubmed publisher
  137. Khoja L, Backen A, Sloane R, Menasce L, Ryder D, Krebs M, et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2012;106:508-16 pubmed publisher
  138. El Sahwi K, Bellone S, Cocco E, Casagrande F, Bellone M, Abu Khalaf M, et al. Overexpression of EpCAM in uterine serous papillary carcinoma: implications for EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201). Mol Cancer Ther. 2010;9:57-66 pubmed publisher
  139. McClelland R, Wauthier E, Uronis J, Reid L. Gradients in the liver's extracellular matrix chemistry from periportal to pericentral zones: influence on human hepatic progenitors. Tissue Eng Part A. 2008;14:59-70 pubmed publisher